Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
NGF signaling via TRKA from the plasma membrane	10/136	0.002238116783878353	1.0	0	0	2.941176470588235	17.947413200595808	SHC2;RIT1;ADCY9;CDKN1B;DUSP3;RPS6KA2;PIK3R2;FOXO3;ADCY6;ADCY5
PAC1 receptor pathway	5/40	0.0030603438504433	1.0	0	0	5.0	28.946139999524515	PRKCH;ADCY9;PLCD4;ADCY6;ADCY5
Signaling by SCF-KIT	7/78	0.003350695028406084	1.0	0	0	3.5897435897435894	20.456467889481193	PTPRU;CDKN1B;FES;KIT;PIK3R2;FOXO3;SOCS6
Notch signaling pathway	9/121	0.0033859637217307616	1.0	0	0	2.975206611570248	16.923322441562156	HES6;HEYL;TLE1;APH1B;MFAP2;DVL3;PIK3R2;EPS15;HES5
Adenylate cyclase inhibitory pathway	3/13	0.003684485563252584	1.0	0	0	9.23076923076923	51.72576337848703	ADCY9;ADCY6;ADCY5
Signaling by NGF	13/221	0.0038695589542352684	0.9738390034825426	0	0	2.352941176470588	13.06968174999734	SHC2;CDKN1B;DUSP3;MCF2;PIK3R2;FOXO3;ADCY6;ADCY5;RIT1;ADCY9;APH1B;RPS6KA2;SOS2
Statin pathway	4/29	0.005583621105065782	1.0	0	0	5.517241379310344	28.622994590353443	ABCA1;APOC1;PLTP;FDFT1
Regulation of transcription by NOTCH1 intracellular domain	5/47	0.006186730331773237	1.0	0	0	4.25531914893617	21.639781062336326	HEYL;TLE1;HDAC11;HDAC6;HES5
LPA4-mediated signaling events	3/16	0.006823799195615574	1.0	0	0	7.5	37.40504171568808	ADCY9;ADCY6;ADCY5
Neural crest differentiation	7/91	0.007793448162696157	1.0	0	0	3.076923076923077	14.93683654587159	CDH1;HDAC11;PAX3;DVL3;ETS1;HDAC6;HES5
PKA activation in glucagon signaling	3/18	0.009582224106397506	1.0	0	0	6.666666666666666	30.985637016835305	ADCY9;ADCY6;ADCY5
Signaling by NOTCH1	6/73	0.009827521468756376	1.0	0	0	3.287671232876712	15.197485532420906	HEYL;TLE1;APH1B;HDAC11;HDAC6;HES5
PI3K pathway	5/53	0.01024902420142917	1.0	0	0	3.7735849056603774	17.285180293547484	SHC2;PRKCH;RPS6KA2;IRS4;SOS2
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	7/97	0.010898290499560565	1.0	0	0	2.8865979381443294	13.044967158205083	HRK;CTSO;PRKCH;KCNIP3;BMF;CTSF;FOXO3
FXR and LXR regulation of cholesterol metabolism	2/7	0.012051662882171474	1.0	0	0	11.428571428571427	50.49774434338215	ABCA1;RXRA
Integration of energy metabolism	8/125	0.013327245294946983	1.0	0	0	2.56	11.053938740966716	DPP4;ADCY9;KCNB1;CACNA1A;VAMP2;ADCY6;SLC25A6;ADCY5
Melanogenesis	7/101	0.013413164283940805	1.0	0	0	2.7722772277227725	11.952724956502475	POMC;ADCY9;KIT;TYRP1;DVL3;ADCY6;ADCY5
Interleukin-4 signaling pathway	7/104	0.015554442504352596	1.0	0	0	2.692307692307692	11.209178048817348	SHC2;FES;IRS4;TFF3;PIK3R2;ETS1;SOS2
Differentiation pathway in PC12 cells	6/84	0.018696947110537213	1.0	0	0	2.8571428571428568	11.369700070200947	SHC2;RIT1;ADCY9;PLCD4;ADCY6;ADCY5
C-Myb transcription factor network	6/85	0.019707152975654504	1.0	0	0	2.8235294117647056	11.087360792274126	CD4;CDKN1B;KIT;NLK;ETS1;SMARCA2
Benzo(a)pyrene metabolism	2/9	0.019987498286726836	1.0	0	0	8.888888888888888	34.779095880349324	EPHX1;CYP1B1
Endothelins	5/64	0.02181970122725916	1.0	0	0	3.125	11.95294372275165	CYSLTR2;PRKCH;ADCY9;ADCY6;ADCY5
Interferon alpha/beta signaling	5/64	0.02181970122725916	1.0	0	0	3.125	11.95294372275165	STAT2;IRF6;HLA-G;IRF9;IFIT2
Insulin signaling pathway	13/277	0.022653771330553355	1.0	0	0	1.8772563176895307	7.109974898381579	SHC2;PRKCH;IRS4;PIK3R2;TSC1;FOXO3;LIPE;PPP1R3C;RPS6KA2;SOS2;VAMP2;MAP3K11;MAP3K12
Vasopressin-regulated water reabsorption	4/44	0.02382609847412197	1.0	0	0	3.6363636363636362	13.58899536203803	RAB5B;ADCY9;ADCY6;VAMP2
Interferon-alpha signaling pathway	2/10	0.02457569018526242	1.0	0	0	8.0	29.64798022792225	STAT2;IRF9
G alpha (z) signaling events	4/45	0.02564991223851159	1.0	0	0	3.5555555555555554	13.024764902655056	PRKCH;ADCY9;ADCY6;ADCY5
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling	4/46	0.02755542815386633	1.0	0	0	3.4782608695652173	12.492367769086824	RXRA;CDH1;LAMB2;MST1R
Apoptotic cleavage of cell adhesion  proteins	2/11	0.02954667996708659	1.0	0	0	7.2727272727272725	25.612973778194785	CDH1;PKP1
Activation of chaperones by IRE1 alpha	4/48	0.03161375502500175	1.0	0	0	3.333333333333333	11.513876558324146	WFS1;CTDSP2;ATP6V0D1;ADD1
HES/HEY pathway	4/48	0.03161375502500175	1.0	0	0	3.333333333333333	11.513876558324146	HES6;CD4;CDKN1B;TLE1
Interleukin-2 signaling pathway	30/847	0.03558971422256175	1.0	0	0	1.4167650531286895	4.725901217290119	CDKN1B;DOCK8;GUCA1A;PBXIP1;PIK3R2;FOXO3;ETS1;DPP4;CTSO;PRKY;STK38;TIMP2;FAM53B;BMF;CTSF;PPP1R16B;EOMES;DUSP3;PTPRN2;TSC22D3;RAB33A;MOB3A;ZEB2;DHRS7;CTDSP2;MALL;MAL;ULK2;IRF9;MXD4
Type I interferon (interferon-alpha/beta) pathway	4/51	0.03832523471749994	1.0	0	0	3.1372549019607843	10.232617191675	PTPRU;STAT2;PTPRM;IRF9
Neurotrophin signaling pathway	7/126	0.0390487132707604	1.0	0	0	2.222222222222222	7.206545231226945	SHC2;RPS6KA2;IRS4;PIK3R2;IRAK3;FOXO3;SOS2
Endometrial cancer	4/52	0.040729689807035306	1.0	0	0	3.076923076923077	9.848609148264439	CDH1;PIK3R2;FOXO3;SOS2
Kit receptor signaling pathway	4/54	0.04578984055205085	1.0	0	0	2.962962962962963	9.136868250298553	KIT;PIK3R2;FOXO3;SOCS6
Non-small cell lung cancer	4/54	0.04578984055205085	1.0	0	0	2.962962962962963	9.136868250298553	RXRA;PIK3R2;FOXO3;SOS2
Visual signal transduction	2/14	0.04654140207685347	1.0	0	0	5.7142857142857135	17.52807425877975	PDE6G;GUCA1A
Glucagon signaling in metabolic regulation	3/33	0.048705626415457094	1.0	0	0	3.6363636363636362	10.988948085170936	ADCY9;ADCY6;ADCY5
Nuclear beta-catenin signaling and target gene transcription regulation	5/80	0.05001216613714395	1.0	0	0	2.5	7.488722451023223	MED12;TLE1;CDH1;SALL4;DVL3
TOR signaling	3/34	0.0524623778440582	1.0	0	0	3.5294117647058822	10.403502278005256	DDIT4L;ULK2;TSC1
Cytochrome P450 metabolism of endogenous sterols	2/15	0.05283270093282616	1.0	0	0	5.333333333333333	15.683333035361262	POMC;CYP1B1
HDL-mediated lipid transport	2/15	0.05283270093282616	1.0	0	0	5.333333333333333	15.683333035361262	ABCA1;PLTP
Neuronal system	12/283	0.0531871237057431	1.0	0	0	1.696113074204947	4.976292207835278	PANX1;KCNK6;ADCY9;KCNS1;KCNB1;RPS6KA2;CACNA1A;VAMP2;ADCY6;GRIA3;GRIN2D;ADCY5
G alpha i pathway	6/108	0.053900162558164676	1.0	0	0	2.222222222222222	6.4902706336673575	SHC2;PRKCH;ADCY9;SOS2;ADCY6;ADCY5
Adrenergic pathway	7/137	0.056647697881061373	1.0	0	0	2.043795620437956	5.867540878657185	PRKCH;ADCY9;PDE6G;PLCD4;PDE9A;ADCY6;ADCY5
KIT signaling regulation	2/16	0.05940541077305161	1.0	0	0	5.0	14.116849831533036	KIT;SOCS6
Signaling by EGFR in cancer	6/111	0.060018518221585736	1.0	0	0	2.1621621621621623	6.082382978058848	ADCY9;CDKN1B;FOXO3;EPS15;ADCY6;ADCY5
mTOR signaling pathway	6/113	0.06431776483525216	1.0	0	0	2.1238938053097343	5.82779342742149	CAB39L;RPS6KA2;VEGFB;ULK2;TSC1;PIK3R2
Progesterone-mediated oocyte maturation	5/86	0.06435408776926937	1.0	0	0	2.325581395348837	6.379894937115337	ADCY9;RPS6KA2;PIK3R2;ADCY6;ADCY5
Activation of NMDA receptor upon glutamate binding and postsynaptic events	3/37	0.06453588403923348	1.0	0	0	3.2432432432432434	8.888217950878486	RPS6KA2;GRIA3;GRIN2D
PI3K/AKT activation	3/37	0.06453588403923348	1.0	0	0	3.2432432432432434	8.888217950878486	CDKN1B;PIK3R2;FOXO3
Branched-chain amino acid catabolism	2/17	0.0662415915707929	1.0	0	0	4.705882352941176	12.773867020503221	ACAD8;AUH
Syndecan 3 pathway	2/17	0.0662415915707929	1.0	0	0	4.705882352941176	12.773867020503221	POMC;APH1B
Unblocking of NMDA receptor, glutamate binding and activation	2/17	0.0662415915707929	1.0	0	0	4.705882352941176	12.773867020503221	GRIA3;GRIN2D
Energy-dependent regulation of mTOR by LKB1-AMPK	2/17	0.0662415915707929	1.0	0	0	4.705882352941176	12.773867020503221	CAB39L;TSC1
EGFR interaction with phospholipase C-gamma	3/38	0.06881998761828545	1.0	0	0	3.157894736842105	8.451350711138838	ADCY9;ADCY6;ADCY5
Iron uptake and transport	3/39	0.07322950908508677	1.0	0	0	3.076923076923077	8.04355941437563	FTH1;CYBRD1;ATP6V0D1
Signaling by NOTCH	6/119	0.07827229040395454	1.0	0	0	2.0168067226890756	5.137939419297049	HEYL;TLE1;APH1B;HDAC11;HDAC6;HES5
PTEN-dependent cell cycle arrest and apoptosis	2/19	0.08063617099611983	1.0	0	0	4.2105263157894735	10.601296667256518	CDKN1B;FOXO3
Glycosaminoglycan degradation	2/19	0.08063617099611983	1.0	0	0	4.2105263157894735	10.601296667256518	HGSNAT;HPSE2
Lysosome	6/121	0.0832740652172301	1.0	0	0	1.9834710743801653	4.930151643404255	PLA2G15;HGSNAT;CTSO;NPC2;CTSF;ATP6V0D1
Signaling by PDGF	6/122	0.085840049639565	1.0	0	0	1.9672131147540983	4.830038562058518	ADCY9;CDKN1B;PIK3R2;FOXO3;ADCY6;ADCY5
cAMP cell motility pathway inferred from amoeba model	4/67	0.08667836668553372	1.0	0	0	2.388059701492537	5.840121660964135	RIPK3;PDE6G;PLCD4;PDE9A
Chondroitin sulfate biosynthesis	2/20	0.08816218183787267	1.0	0	0	4.0	9.714308741076266	CHST9;BCAN
Interleukin-3 regulation of hematopoietic cells	2/20	0.08816218183787267	1.0	0	0	4.0	9.714308741076266	CYSLTR2;KIT
Insulin secretion regulation by glucagon-like peptide-1	3/43	0.0920646511043347	1.0	0	0	2.7906976744186043	6.656551309777228	KCNB1;ADCY6;ADCY5
E-cadherin keratinocyte pathway	2/21	0.09588684119947874	1.0	0	0	3.8095238095238093	8.931758172484527	CDH1;CTNND1
G-protein-mediated events	3/44	0.09705771960273352	1.0	0	0	2.727272727272727	6.361225718177528	ADCY9;ADCY6;ADCY5
Renal cell carcinoma	4/70	0.09798976602376523	1.0	0	0	2.2857142857142856	5.309467963642306	VEGFB;PIK3R2;ETS1;SOS2
Granule cell survival pathway	5/99	0.10244796021859995	1.0	0	0	2.02020202020202	4.602828918210063	KCNK6;ADCY9;PLCD4;ADCY6;ADCY5
Chemokine signaling pathway	8/189	0.10259067670310733	1.0	0	0	1.693121693121693	3.855252013908168	SHC2;ADCY9;STAT2;PIK3R2;FOXO3;SOS2;ADCY6;ADCY5
Transmission across chemical synapses	8/190	0.10490832462542346	1.0	0	0	1.6842105263157894	3.797336267794302	ADCY9;RPS6KA2;CACNA1A;GRIA3;VAMP2;ADCY6;GRIN2D;ADCY5
RhoA activity regulation	3/46	0.10736313441562158	1.0	0	0	2.6086956521739126	5.821404549935052	FARP1;CDKN1B;MCF2
Chronic myeloid leukemia	4/73	0.10995046855934236	1.0	0	0	2.191780821917808	4.838849973529832	SHC2;CDKN1B;PIK3R2;SOS2
Myc repressed pathway	4/73	0.10995046855934236	1.0	0	0	2.191780821917808	4.838849973529832	CDKN1B;FTH1;FOXO3;MXD4
Eicosanoid metabolism	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	CYSLTR2;EPHX1
Visual signal transduction: rods	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	PDE6G;GUCA1A
Signaling by ERBB2	5/102	0.11254203614215841	1.0	0	0	1.9607843137254901	4.283193083396457	ADCY9;CDKN1B;FOXO3;ADCY6;ADCY5
Adherens junction cell adhesion	4/74	0.11407613801901988	1.0	0	0	2.1621621621621623	4.693814434937615	CDH1;CTNND1;PTPRM;NLK
Wnt/calcium/cyclic GMP pathway	4/74	0.11407613801901988	1.0	0	0	2.1621621621621623	4.693814434937615	PRKCH;PDE6G;PLCD4;NFATC4
Presenilin action in Notch and Wnt signaling	3/48	0.11807273003133849	1.0	0	0	2.5	5.341136220470389	APH1B;TLE1;NLK
Lipid digestion, mobilization, and transport	3/48	0.11807273003133849	1.0	0	0	2.5	5.341136220470389	ABCA1;LIPE;PLTP
Blockade of neurotransmitter release by botulinum toxin	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	VAMP2
Catalytic cycle of mammalian FMOs	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	FMO5
Cytochrome P450 metabolism of miscellaneous substrates	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	CYP2U1
Electric transmission across gap junctions	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	PANX1
Folate-alcohol and cancer pathway	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	CBS
Kit receptor transcriptional targets	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	KIT
Leukotriene receptors	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	CYSLTR2
Plexin D1 signaling	2/24	0.12010982001247623	1.0	0	0	3.333333333333333	7.064495959797489	PLXND1;RND2
Dorso-ventral axis formation	2/24	0.12010982001247623	1.0	0	0	3.333333333333333	7.064495959797489	ETS1;SOS2
Amoebiasis	5/105	0.12309486929886125	1.0	0	0	1.9047619047619047	3.99009509674713	RAB5B;LAMB2;PIK3R2;SERPINB9;SERPINB6
Fibroblast growth factor receptor pathway	5/105	0.12309486929886125	1.0	0	0	1.9047619047619047	3.99009509674713	SHC2;PRKCH;RPS6KA2;PIK3R2;SOS2
Interleukin-5 signaling pathway	3/49	0.12357090514220292	1.0	0	0	2.4489795918367343	5.120669772142008	CD4;PIK3R2;FOXO3
FSH regulation of apoptosis	10/263	0.12499483608691939	1.0	0	0	1.520912547528517	3.1627115647723443	DAB2;ADCY9;DUSP3;NPC2;CTNND1;ZBED1;CREBL2;PTGDS;NLK;COX7A1
Glutathione conjugation	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	GSTP1;OPLAH
Aquaporin-mediated transport	3/50	0.12916025190606503	1.0	0	0	2.4	4.912083318606716	ADCY9;ADCY6;ADCY5
Type 2 diabetes mellitus	3/50	0.12916025190606503	1.0	0	0	2.4	4.912083318606716	IRS4;CACNA1A;PIK3R2
Type II interferon signaling (interferon-gamma)	3/50	0.12916025190606503	1.0	0	0	2.4	4.912083318606716	STAT2;IRF9;IFIT2
Natural killer cell-mediated cytotoxicity	6/137	0.12936659917835788	1.0	0	0	1.7518248175182483	3.582665782699951	SHC2;PIK3R2;HLA-G;SOS2;NFATC4;TNFRSF10D
Glutathione metabolism	3/51	0.13483744322316818	1.0	0	0	2.352941176470588	4.714553765545066	GSTP1;GPX7;OPLAH
Unfolded protein response	4/79	0.13568722199833994	1.0	0	0	2.0253164556962022	4.045372921890401	WFS1;CTDSP2;ATP6V0D1;ADD1
RXR/VDR pathway	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	ABCA1;RXRA
Signaling by insulin receptor	5/109	0.13784796080850112	1.0	0	0	1.834862385321101	3.6359705219282574	SHC2;CAB39L;TSC1;PIK3R2;ATP6V0D1
Apoptosis modulation and signaling	4/80	0.14019643720239597	1.0	0	0	2.0	3.9294214339112856	HRK;MADD;BMF;TNFRSF10D
Opioid signaling	4/80	0.14019643720239597	1.0	0	0	2.0	3.9294214339112856	POMC;ADCY9;ADCY6;ADCY5
Apoptotic execution  phase	3/52	0.14059914501552925	1.0	0	0	2.3076923076923075	4.527328570603137	CDH1;PKP1;ADD1
Taste transduction	3/52	0.14059914501552925	1.0	0	0	2.3076923076923075	4.527328570603137	KCNB1;CACNA1A;ADCY6
RSK activation	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	RPS6KA2
Influenza factor interactions with host	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	SLC25A6
MSP/RON receptor signaling pathway	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	MST1R
Multi-drug resistance factors	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	GSTP1
Leptin influence on immune response	5/110	0.14165333955886242	1.0	0	0	1.8181818181818181	3.553404503369429	CD79B;ABCA1;CD4;IFIT2;BATF
Epidermal growth factor receptor (EGFR) pathway	5/111	0.14550403989770552	1.0	0	0	1.8018018018018016	3.47306563447942	SHC2;PRKCH;RPS6KA2;PIK3R2;SOS2
CTCF pathway	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	CD79B;CDKN1B
VEGFR1 pathway	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	SHC2;VEGFB
Androgen receptor regulation of biosynthesis and transcription	3/53	0.14644202157094957	1.0	0	0	2.2641509433962264	4.349718534458366	RXRA;SMARCA2;PDE9A
GABA A and B receptor activation	3/53	0.14644202157094957	1.0	0	0	2.2641509433962264	4.349718534458366	ADCY9;ADCY6;ADCY5
JNK/MAPK pathway	3/53	0.14644202157094957	1.0	0	0	2.2641509433962264	4.349718534458366	SHC2;MAP3K11;MAP3K12
Metapathway biotransformation	7/174	0.14677981394224443	1.0	0	0	1.6091954022988504	3.087759024421808	CHST9;CYP2U1;GSTP1;EPHX1;CYP1B1;HNMT;FMO5
ATM-dependent DNA damage response	4/82	0.14939050479141397	1.0	0	0	1.951219512195122	3.709642075934028	CDKN1B;DVL3;FOXO3;SOS2
Phospholipase C-mediated cascade	3/54	0.15236274042928305	1.0	0	0	2.222222222222222	4.1810914466514895	ADCY9;ADCY6;ADCY5
Oocyte meiosis	5/113	0.15333823216929846	1.0	0	0	1.7699115044247786	3.3187772207916013	ADCY9;RPS6KA2;ADCY6;REC8;ADCY5
Drug metabolism: cytochrome P450	4/83	0.15407242259021772	1.0	0	0	1.927710843373494	3.605460261308949	GSTP1;EPHX1;CYP1B1;FMO5
Apoptosis	9/242	0.15409546113463288	1.0	0	0	1.487603305785124	2.7820904000066613	HRK;CDH1;PKP1;PIK3R2;BMF;IRAK3;IRF6;ADD1;TNFRSF10D
TRAIL signaling pathway	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	PIK3R2;TNFRSF10D
Nitric oxide stimulation of guanylate cyclase	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	PDE6G;PDE9A
PKB-mediated events	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	CAB39L;TSC1
Small cell lung cancer	4/84	0.15880894471190304	1.0	0	0	1.9047619047619047	3.5048636282938084	CDKN1B;RXRA;LAMB2;PIK3R2
Cell junction organization	4/84	0.15880894471190304	1.0	0	0	1.9047619047619047	3.5048636282938084	CDH1;CTNND1;CLDN7;LIMS2
Antigen-activated B-cell receptor generation of second messengers	8/211	0.16001373056165924	1.0	0	0	1.5165876777251186	2.7791403244283197	CD79B;SHC2;CD4;PRKCH;PIK3R2;ETS1;SOS2;NFATC4
Arachidonate epoxygenase/epoxide hydrolase pathway	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	GSTP1
CREB phosphorylation	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	RPS6KA2
Viral dsRNA-TLR3-TRIF complex activation of RIP1	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	RIPK3
Glucocorticoid biosynthesis	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	POMC
Phototransduction	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	PDE6G;GUCA1A
Adherens junction actin cytoskeletal organization	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	CDH1;CTNND1
Association of TriC/CCT with target proteins during biosynthesis	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	FBXW4;FBXL5
Thyroid cancer	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	RXRA;CDH1
Inhibition of insulin secretion by adrenaline/noradrenaline	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	ADCY6;ADCY5
Lipoprotein metabolism	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	ABCA1;PLTP
Calcium regulation in the cardiac cell	6/149	0.17044793665898042	1.0	0	0	1.610738255033557	2.8499200843945487	PRKCH;ADCY9;KCNB1;CACNA1A;ADCY6;ADCY5
Acute myeloid leukemia	3/57	0.1705587717216263	1.0	0	0	2.1052631578947367	3.723527030473866	KIT;PIK3R2;SOS2
Nectin adhesion pathway	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	CDH1;PTPRM
Nuclear events mediated by MAP kinases	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	DUSP3;RPS6KA2
Arachidonic acid metabolism	3/58	0.17675775807092875	1.0	0	0	2.068965517241379	3.5854656874425306	CYP2U1;GPX7;PTGDS
Alpha-6 beta-4 integrin signaling pathway	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	LAMB2;PIK3R2
Amino acid transport across the plasma membrane	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	SLC6A6;SLC38A5
Integrated breast cancer pathway	6/152	0.1814837820990341	1.0	0	0	1.5789473684210524	2.694614185414532	GRN;RASGEF1A;CDH1;MYCBP2;TSC1;PIK3R2
G alpha s pathway	5/120	0.18206485655756022	1.0	0	0	1.6666666666666665	2.838987167787887	ADCY9;PDE6G;PDE9A;ADCY6;ADCY5
Prostate cancer	4/89	0.1832574394336419	1.0	0	0	1.797752808988764	3.050540839293841	CDKN1B;GSTP1;PIK3R2;SOS2
Salivary secretion	4/89	0.1832574394336419	1.0	0	0	1.797752808988764	3.050540839293841	ADCY9;VAMP2;ADCY6;ADCY5
Proepithelin conversion to epithelin and wound repair control	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	GRN
Aflatoxin B1 metabolism	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	EPHX1
Relaxin receptors	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	RLN2
Beta-oxidation of pristanoyl-CoA	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	ACOX3
Bystander B cell activation	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	CD4
Chromatin remodeling by nuclear receptors to facilitate initiation of transcription in carcinoma cells	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	RXRA
Transport of nucleotide sugars	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	SLC35A1
Visceral fat deposits and the metabolic syndrome	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	RXRA
Vitamin D biosynthesis	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	RXRA
Formyl peptide interaction with formyl peptide receptors	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	HEBP1
Mitotic metaphase/anaphase transition	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	REC8
Nicotinate metabolism	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	NADSYN1
Gap junction pathway	4/90	0.18828953531711135	1.0	0	0	1.7777777777777777	2.968487856688808	ADCY9;SOS2;ADCY6;ADCY5
Sphingolipid de novo biosynthesis	2/32	0.1902017379712103	1.0	0	0	2.5	4.149174978285558	CERS4;COL4A3BP
Glycine, serine and threonine metabolism	2/32	0.1902017379712103	1.0	0	0	2.5	4.149174978285558	SRR;CBS
Hypothetical network for drug addiction	2/32	0.1902017379712103	1.0	0	0	2.5	4.149174978285558	GRIA3;GRIN2D
Pathways in cancer	11/325	0.19266186896574186	1.0	0	0	1.3538461538461537	2.229539028842822	CDKN1B;RXRA;CDH1;LAMB2;GSTP1;KIT;VEGFB;DVL3;PIK3R2;ETS1;SOS2
Clathrin derived vesicle budding	3/61	0.19571013951815233	1.0	0	0	1.9672131147540983	3.2087618250165857	FTH1;HIP1R;VAMP2
Signaling by ERBB4	4/93	0.2036425912242253	1.0	0	0	1.7204301075268817	2.737873248162342	WWOX;CDKN1B;APH1B;FOXO3
G alpha (s) signaling events	5/125	0.2037060161721424	1.0	0	0	1.5999999999999999	2.545723874740078	POMC;ADCY9;RLN2;ADCY6;ADCY5
AKT phosphorylation of nuclear targets	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	FOXO3
Alpha defensins	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	CD4
Pyrimidine salvage reactions	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	TK2
Endosomal/vacuolar pathway	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	HLA-G
cAMP receptor, G-protein-independent pathways inferred from amoeba model	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	STAT2
HIV-induced T cell apoptosis	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	CD4
Heme biosynthesis	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	ALAD
Inhibition of matrix metalloproteinases	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	TIMP2
Ketone body biosynthesis and degradation	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	BDH2
Nef-mediated CD4 downregulation	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	CD4
PPAR-gamma coactivator role in obesity and thermogenesis	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	RXRA
ERBB signaling pathway	4/94	0.20884064659492504	1.0	0	0	1.7021276595744679	2.665844722244623	SHC2;CDKN1B;PIK3R2;SOS2
G-protein signaling pathways	4/95	0.21407627612000896	1.0	0	0	1.6842105263157894	2.5960806686302367	PRKCH;ADCY9;ADCY6;ADCY5
Signaling by FGFR in disease	5/128	0.2170847599208247	1.0	0	0	1.5625	2.3866678171750295	ADCY9;CDKN1B;FOXO3;ADCY6;ADCY5
Primary immunodeficiency	2/35	0.21773131350006625	1.0	0	0	2.2857142857142856	3.484556533108	CD4;RAG1
Autophagy regulation	2/35	0.21773131350006625	1.0	0	0	2.2857142857142856	3.484556533108	ULK2;GABARAP
Interleukin-7 signaling pathway	2/35	0.21773131350006625	1.0	0	0	2.2857142857142856	3.484556533108	CDKN1B;PIK3R2
PIK3C1/AKT pathway	2/35	0.21773131350006625	1.0	0	0	2.2857142857142856	3.484556533108	CDKN1B;FOXO3
Cell-cell communication	5/129	0.2216043819346316	1.0	0	0	1.5503875968992247	2.336219457722892	CDH1;CTNND1;CLDN7;PIK3R2;LIMS2
ERK1/ERK2 MAPK pathway	3/65	0.2216910070831208	1.0	0	0	1.8461538461538463	2.7811767260910543	SHC2;RPS6KA2;SOS2
Glioma	3/65	0.2216910070831208	1.0	0	0	1.8461538461538463	2.7811767260910543	SHC2;PIK3R2;SOS2
LPA receptor mediated events	3/65	0.2216910070831208	1.0	0	0	1.8461538461538463	2.7811767260910543	ADCY9;ADCY6;ADCY5
Androgen biosynthesis	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	POMC
Rheb GTPase activity by AMPK regulation	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	TSC1
Dermatan sulfate biosynthesis	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	BCAN
Electron transport reaction in mitochondria	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	SLC25A6
Ganglio sphingolipid metabolism	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	B3GALT4
Gap junction degradation	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	DAB2
Interferon-gamma signaling pathway	4/97	0.22465400248636988	1.0	0	0	1.6494845360824741	2.4630001271451514	IRF6;HLA-G;MAP3K11;IRF9
SNARE interactions in vesicular transport	2/36	0.22698728149273847	1.0	0	0	2.222222222222222	3.2952473149705526	STX18;VAMP2
Signaling to ERKs	2/36	0.22698728149273847	1.0	0	0	2.222222222222222	3.2952473149705526	SHC2;RIT1
Thyroid-stimulating hormone signaling pathway	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	CDKN1B;KCNIP3;PIK3R2
Wnt signaling pathway and pluripotency	4/98	0.2299929805556841	1.0	0	0	1.6326530612244896	2.3995207997514747	PRKCH;CTNND1;DVL3;NLK
Adipocytokine signaling pathway	3/67	0.23493078009641188	1.0	0	0	1.7910447761194028	2.594264527179215	POMC;RXRA;IRS4
G alpha 13 pathway	3/67	0.23493078009641188	1.0	0	0	1.7910447761194028	2.594264527179215	PRKCH;MAP3K11;MAP3K12
Cell adhesion molecules (CAMs)	5/133	0.23995771281939338	1.0	0	0	1.5037593984962405	2.1463046131585695	CD4;CDH1;CLDN7;PTPRM;HLA-G
AMPK signaling	3/68	0.2416025942539262	1.0	0	0	1.7647058823529411	2.5066960150114252	LIPE;TSC1;PIK3R2
Acetylcholine neurotransmitter release cycle	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	VAMP2
Regulated proteolysis of p75 neurotrophin receptor	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	APH1B
SUMOylation as a mechanism to modulate CtBP-dependent gene responses	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	CDH1
Signaling by VEGF	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	VEGFB
Tryptophan catabolism	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	HAAO
Glutathione biosynthesis and recycling	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	OPLAH
Integrin beta-4 pathway	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	LAMB2
Keratan sulfate degradation	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	PRELP
Methylation	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	HNMT
Norepinephrine neurotransmitter release cycle	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	VAMP2
Notch receptor processing	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	APH1B
Interferon signaling	6/168	0.24460711115245393	1.0	0	0	1.4285714285714284	2.011574262248821	UBA7;STAT2;IRF6;HLA-G;IRF9;IFIT2
Signaling events mediated by HDAC class II	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	HDAC11;HDAC6
ERBB4 signaling events	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	WWOX;PIK3R2
Pancreatic secretion	4/101	0.24619177364498787	1.0	0	0	1.584158415841584	2.220426897571902	ADCY9;ADCY6;TPCN2;ADCY5
GnRH signaling pathway	4/101	0.24619177364498787	1.0	0	0	1.584158415841584	2.220426897571902	ADCY9;SOS2;ADCY6;ADCY5
Phase I of biological oxidations: functionalization of compounds	3/69	0.24830518328238543	1.0	0	0	1.7391304347826086	2.4227768897492368	POMC;CYP2U1;CYP1B1
PPAR signaling pathway	3/69	0.24830518328238543	1.0	0	0	1.7391304347826086	2.4227768897492368	RXRA;ACOX3;PLTP
E-cadherin nascent AJ-like junctions pathway	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	CDH1;CTNND1
Vitamin A and carotenoid metabolism	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	RXRA;RETSAT
GAB1 signalosome	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	CDKN1B;FOXO3
CDC42 signaling events	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	CDH1;HES5;MAP3K11
Signaling events mediated by HDAC class I	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	HDAC11;SIRT2;HDAC6
Diabetes pathways	5/137	0.2587049099112584	1.0	0	0	1.45985401459854	1.97382074569392	WFS1;CTDSP2;ATP6V0D1;VAMP2;ADD1
Bacterial invasion of epithelial cells	3/71	0.26179144524840503	1.0	0	0	1.6901408450704225	2.2651387651401085	SHC2;CDH1;PIK3R2
Peptide hormone biosynthesis	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	POMC
Phospholipase C epsilon pathway	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	RAP2B
Reversible hydration of carbon dioxide	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	CA14
SODD/TNFR1 signaling pathway	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	MADD
Caspase-mediated cleavage of cytoskeletal proteins	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	ADD1
Tandem pore domain potassium channels	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	KCNK6
Dopamine neurotransmitter release cycle	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	VAMP2
ERK inactivation	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	DUSP3
Gamma-aminobutyric acid receptor life cycle	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	GABARAP
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	LIPE
Iron metabolism in placenta	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	FTH1
Opening of calcium channels triggered by depolarization of the presynaptic terminal	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	CACNA1A
Nuclear signaling by ErbB4	2/40	0.2642113633345378	1.0	0	0	2.0	2.662011754937148	WWOX;APH1B
Biological oxidations	5/139	0.26820709009249616	1.0	0	0	1.4388489208633093	1.8935192412132424	POMC;CYP2U1;GSTP1;CYP1B1;OPLAH
Sphingolipid metabolism	3/72	0.2685696227705788	1.0	0	0	1.6666666666666665	2.1910751599377134	CERS4;NEU3;COL4A3BP
ERBB1 internalization pathway	2/41	0.2735343283108339	1.0	0	0	1.951219512195122	2.529420780778097	PIK3R2;EPS15
Alpha-hemoglobin stabilizing enzyme (AHSP) pathway	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	ALAD
Signal attenuation	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	SHC2
Chondroitin sulfate/dermatan sulfate degradation	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	BCAN
T helper cell surface molecules	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	CD4
p27 phosphorylation regulation during cell cycle progression	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	CDKN1B
Glucose-dependent insulinotropic polypeptide (GIP) biosynthesis, secretion, and inactivation	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	DPP4
HIV life cycle early phase	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	CD4
Lck and Fyn tyrosine kinases in initiation of T cell receptor activation	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	CD4
Melanocyte development and pigmentation pathway	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	KIT
N-glycan trimming in the ER and calnexin/calreticulin cycle	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	MLEC
E2F transcription factor network	3/74	0.28218271785894006	1.0	0	0	1.6216216216216217	2.051676457611424	CDKN1B;SMARCA2;CES4A
Gastric acid secretion	3/74	0.28218271785894006	1.0	0	0	1.6216216216216217	2.051676457611424	ADCY9;ADCY6;ADCY5
Aldosterone-regulated sodium reabsorption	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	IRS4;PIK3R2
Bladder cancer	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	CDH1;VEGFB
Calcium signaling pathway	6/178	0.28690868886067566	1.0	0	0	1.348314606741573	1.6834938487080762	CYSLTR2;ADCY9;CACNA1A;PLCD4;GRIN2D;SLC25A6
Porphyrin and chlorophyll metabolism	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	ALAD;FTH1
Type 1 diabetes mellitus	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	PTPRN2;HLA-G
Voltage-gated potassium channels	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	KCNS1;KCNB1
VEGF signaling pathway	3/76	0.2958542767561014	1.0	0	0	1.5789473684210524	1.9229814539020869	SHC2;PIK3R2;NFATC4
Glycosaminoglycan metabolism	4/110	0.29606967026845615	1.0	0	0	1.4545454545454544	1.77041524338222	BCAN;CHST9;HPSE2;PRELP
AKT phosphorylation of cytosolic targets	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	CDKN1B
Activation of Rac	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	SOS2
Porphyrin metabolism	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	ALAD
Sema3A-plexin repulsion signaling by inhibiting integrin adhesion	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	FES
CARM1 transcriptional regulation by protein methylation	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	RXRA
Signaling by NOTCH2	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	APH1B
Glycosphingolipid biosynthesis: globo series	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	GBGT1
MAP kinase inactivation of SMRT corepressor	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	RXRA
ERBB2/ERBB3 signaling events	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	PIK3R2;NFATC4
Valine, leucine and isoleucine degradation	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	ACAD8;AUH
Heart development	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	VEGFB;NFATC4
PI3K events in ERBB2 signaling	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	CDKN1B;FOXO3
G alpha (12/13) signaling events	3/77	0.30270573541973567	1.0	0	0	1.5584415584415583	1.8623284918379568	MCF2;PIK3R2;SOS2
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	4/112	0.30733899532659725	1.0	0	0	1.4285714285714284	1.6854341732739702	ABCA1;MED12;RXRA;FDFT1
Repression of pain sensation by the transcriptional regulator DREAM	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	KCNIP3
Sema3A/PAK-dependent axon repulsion	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	FES
Signaling to p38 via RIT and RIN	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	RIT1
Coagulation intrinsic pathway	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	SERPING1
Eicosanoid ligand-binding G-protein coupled receptors	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	CYSLTR2
Glycosphingolipid biosynthesis: ganglio series	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	B3GALT4
Hematopoiesis regulation by cytokines	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	CD4
Interleukin-17 signaling pathway	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	CD4
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	3/79	0.3164279982103083	1.0	0	0	1.5189873417721518	1.747837301901023	CDH1;ETS1;EPS15
TGF-beta signaling pathway	6/185	0.3173942119499871	1.0	0	0	1.2972972972972974	1.4887922683828538	DAB2;ZEB2;CDH1;PIK3R2;ZNF423;ETS1
Fas signaling pathway	4/115	0.3243198596460406	1.0	0	0	1.391304347826087	1.5666435186676206	PIK3R2;MAP3K11;NFATC4;MAP3K12
ABC transporters	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	ABCA1;ABCG4
LKB1 signaling events	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	TSC1;SIK2
Vascular smooth muscle contraction	4/116	0.32999523901017713	1.0	0	0	1.379310344827586	1.5292097267138929	PRKCH;ADCY9;ADCY6;ADCY5
MAP kinase signaling pathway	3/81	0.3301606795473307	1.0	0	0	1.4814814814814814	1.6417419782274463	RPS6KA2;MAP3K11;MAP3K12
SREBF and miR-33 in cholesterol and lipid homeostasis	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	ABCA1
Selenium metabolism and selenoproteins	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	SELENBP1
CRMPs in Sema3A signaling	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	FES
Cell death signaling by NRIF in the nucleus	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	APH1B
Cell-extracellular matrix interactions	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	LIMS2
GluR2-containing AMPA receptor trafficking	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	GRIA3
Glutamate neurotransmitter release cycle	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	VAMP2
Interleukin-9 signaling pathway	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	PIK3R2
Nucleotide-like (purinergic) G-protein coupled receptors	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	P2RY12
Other glycan degradation	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	NEU3
Other semaphorin interactions	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	PLXND1
Post-translational regulation of adherens junction stability and disassembly	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	CDH1;CTNND1
Chondroitin sulfate/dermatan sulfate metabolism	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	CHST9;BCAN
Diurnally regulated genes with circadian orthologs	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	PPP1R3C;GSTP1
Energy metabolism	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	RXRA;FOXO3
TGF-beta regulation of extracellular matrix	16/565	0.34062273071404003	1.0	0	0	1.1327433628318584	1.219941692840484	KCNE3;AEBP1;HNMT;SELENBP1;DPP4;HEBP1;HEYL;ARMCX1;NPC2;CBS;APOC1;STK38;CYP1B1;OSBPL1A;SOS2;IRF9
T cell signal transduction	3/83	0.34388610305783524	1.0	0	0	1.4457831325301203	1.5432936465472034	PRKCH;SOS2;NFATC4
Amino acid and oligopeptide SLC transporters	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	SLC6A6;SLC38A5
Angiopoietin receptor Tie2-mediated signaling	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	FES;ETS1
Arf6 integrin-mediated signaling pathway	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	CDH1;CTNND1
Ceramide signaling pathway	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	KSR1;MADD
FoxO family signaling	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	CDKN1B;FOXO3
ABCA transporters in lipid homeostasis	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	ABCG4
Activation of BH3-only proteins	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	BMF
SHC-related events	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	SHC2
SUMOylation by RanBP2 regulates transcriptional repression	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	HDAC6
Cell to cell adhesion signaling	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	CDH1
Synaptic proteins at the synaptic junction	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	ADD1
Endocytotic role of NDK, phosphins and dynamin	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	EPS15
Estrogen metabolism	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	CYP1B1
G1/S-specific transcription	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	TK2
Glycosylphosphatidylinositol (GPI) biosynthesis	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	PIGQ
Inflammasomes	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	PANX1
NO2-dependent IL-12 pathway in NK cells	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	CD4
Metabolism	43/1615	0.35477431811383564	1.0	0	0	1.0650154798761609	1.1036472286654997	HPSE2;PIGQ;GSTP1;HAAO;TYRP1;CACNA1A;PIK3R2;OPLAH;NADSYN1;ADCY6;ADCY5;MED12;ALAD;DPP4;LIPE;NEU3;COL4A3BP;AUH;CBS;UAP1L1;CYP1B1;TK2;PTGDS;CA14;FDFT1;ABCA1;ACAD8;CHST9;CERS4;HGSNAT;ALG9;KCNB1;B3GALT4;GBGT1;BCAN;ADCY9;BDH2;CYP2U1;CRYL1;GALNTL6;ACOX3;ATP6V0D1;PLCD4
Activated AMPK stimulation of fatty-acid oxidation in muscle	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	CAB39L
Bone remodeling	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	IRF9
Botulinum neurotoxicity	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	VAMP2
CBL signaling regulation	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	PIK3R2
CDK regulation of DNA replication	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	CDKN1B
Sodium/chloride-dependent neurotransmitter transporters	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	SLC6A6
Tie2 signaling	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	PIK3R2
Transcriptional activity regulation by PML	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	PAX3
Downregulation of MTA-3 in ER-negative breast tumors	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	CDH1
Effect of METS on macrophage differentiation	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	ETS1
Nicotinic acetylcholine receptor role in the regulation of apoptosis	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	FOXO3
Rho GTPase cycle	4/123	0.36980155943674486	1.0	0	0	1.3008130081300813	1.294034137319875	MCF2;FAM13A;PIK3R2;SOS2
Signaling events mediated by stem cell factor receptor (c-Kit)	2/52	0.3746429686919478	1.0	0	0	1.5384615384615385	1.5104335231065098	KIT;FOXO3
Vitamin B12 metabolism	2/52	0.3746429686919478	1.0	0	0	1.5384615384615385	1.5104335231065098	ABCA1;CBS
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) metabolism	2/52	0.3746429686919478	1.0	0	0	1.5384615384615385	1.5104335231065098	BCAN;HPSE2
Androgen receptor signaling, proteolysis, and transcription regulation	3/88	0.3780598863986252	1.0	0	0	1.3636363636363635	1.3264127267525516	POMC;PIK3R2;BMF
Hematopoietic cell lineage	3/88	0.3780598863986252	1.0	0	0	1.3636363636363635	1.3264127267525516	CD4;KIT;CD59
G alpha (i) signaling events	6/199	0.3795402740781548	1.0	0	0	1.2060301507537687	1.168395453737611	P2RY12;HEBP1;POMC;ADCY9;ADCY6;ADCY5
Jak-STAT signaling pathway	6/199	0.3795402740781548	1.0	0	0	1.2060301507537687	1.168395453737611	PTPRU;STAT2;PTPRM;PIK3R2;SOS2;IRF9
Alpha-linolenic acid metabolism	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	ACOX3
Ras activation upon calcium influx through NMDA receptor	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	GRIN2D
Signaling by NODAL	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	FOXO3
Calcineurin in effects in keratinocyte differentiation	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	NFATC4
Tamoxifen metabolism	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	CYP1B1
Eicosanoid biosynthesis	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	PTGDS
GABA biosynthesis, release, reuptake and degradation	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	VAMP2
IGF-1 receptor and longevity	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	FOXO3
Inhibition of T cell receptor signaling by activated Csk	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	CD4
MAL role in Rho-mediated activation of SRF	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	MAL
Protein folding	2/53	0.38359202335177106	1.0	0	0	1.5094339622641508	1.4463029892393837	FBXW4;FBXL5
Amyotrophic lateral sclerosis (ALS)	2/53	0.38359202335177106	1.0	0	0	1.5094339622641508	1.4463029892393837	NEFH;GRIN2D
MAPK signaling pathway	9/314	0.3860501672296229	1.0	0	0	1.1464968152866242	1.0912218547025954	PRKCH;DUSP3;RPS6KA2;CACNA1A;NLK;SOS2;MAP3K11;NFATC4;MAP3K12
Endocytosis	6/201	0.38846981218186155	1.0	0	0	1.1940298507462686	1.1290027650329573	RAB5B;DAB2;CHMP1B;KIT;HLA-G;EPS15
Purine metabolism	5/164	0.3909890499800005	1.0	0	0	1.2195121951219512	1.145214298238003	ADCY9;PDE6G;PDE9A;ADCY6;ADCY5
Peroxisomal lipid metabolism	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	ACOX3
Dual incision reaction in GG-NER	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	ERCC5
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) degradation	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	HPSE2
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	8/280	0.4012477326520312	1.0	0	0	1.1428571428571428	1.0436300060175148	UBA7;STAT2;PIK3R2;IRAK3;IRF6;HLA-G;IRF9;IFIT2
Vibrio cholerae infection	2/55	0.40132045183103177	1.0	0	0	1.4545454545454544	1.3279927840918175	ADCY9;ATP6V0D1
Prion pathway	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	LAMB2
Biosynthesis of unsaturated fatty acids	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	ACOX3
CD28-dependent PI3K/Akt signaling	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	PIK3R2
Cytosolic sensors of pathogen-associated DNA	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	RIPK3
PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	CACNA1A
Keratinocyte differentiation	2/57	0.41880475936093825	1.0	0	0	1.4035087719298245	1.2215444712550116	PRKCH;ETS1
PI3K cascade	2/57	0.41880475936093825	1.0	0	0	1.4035087719298245	1.2215444712550116	CDKN1B;FOXO3
Adipogenesis	4/133	0.42630173637085006	1.0	0	0	1.2030075187969924	1.0256936927515796	LIPE;RXRA;STAT2;IRS4
Membrane trafficking	4/133	0.42630173637085006	1.0	0	0	1.2030075187969924	1.0256936927515796	DAB2;FTH1;HIP1R;VAMP2
AKT signaling pathway	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	FOXO3
T cell receptor downstream signaling	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	CD4
Nephrin interactions	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	PIK3R2
Nitric oxide signaling pathway	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	GRIN2D
Tryptophan metabolism	2/58	0.4274492922819714	1.0	0	0	1.379310344827586	1.1723029133595582	HAAO;CYP1B1
ATF2 transcription factor network	2/59	0.43602582146324703	1.0	0	0	1.3559322033898304	1.1254966967419524	HRK;JDP2
Angiogenesis	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	TIMP2
Signaling by bone morphogenetic protein (BMP)	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	FSTL1
Signaling events mediated by the hedgehog family	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	DISP1
Cyclins and cell cycle regulation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	CDKN1B
Visual signal transduction: cones	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	GUCA1A
Incretin biosynthesis, secretion, and inactivation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	DPP4
Nitrogen metabolism	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	CA14
Selenium pathway	2/60	0.4445323414545099	1.0	0	0	1.3333333333333333	1.0809766233296643	ABCA1;CBS
Natural killer cell receptor signaling pathway	2/60	0.4445323414545099	1.0	0	0	1.3333333333333333	1.0809766233296643	SHC2;SOS2
Neurotrophic factor-mediated Trk receptor signaling	2/60	0.4445323414545099	1.0	0	0	1.3333333333333333	1.0809766233296643	SHC2;RIT1
Potassium channels	3/99	0.45159604781162715	1.0	0	0	1.2121212121212122	0.9635966039626941	KCNK6;KCNS1;KCNB1
Cytochrome P450 pathway	2/61	0.4529669891745948	1.0	0	0	1.3114754098360655	1.0386046265359035	CYP2U1;CYP1B1
FGF signaling pathway	2/61	0.4529669891745948	1.0	0	0	1.3114754098360655	1.0386046265359035	CDH1;CTNND1
Cholesterol biosynthesis	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	FDFT1
Sulfur amino acid metabolism	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	CBS
Triacylglyceride biosynthesis	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	LIPE
Lysosome vesicle biogenesis	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	VAMP2
Nicotinate and nicotinamide metabolism	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	NADSYN1
Dilated cardiomyopathy	3/100	0.4581166423834544	1.0	0	0	1.2	0.9367577395196145	ADCY9;ADCY6;ADCY5
T cell receptor signaling pathway	4/139	0.4596056772594075	1.0	0	0	1.1510791366906474	0.8948332437112545	CD4;PIK3R2;SOS2;NFATC4
Signaling events mediated by focal adhesion kinase	2/62	0.46132803795917154	1.0	0	0	1.2903225806451613	0.9982527870331739	KLF8;ETS1
TNF-alpha signaling pathway	3/101	0.4646041358021239	1.0	0	0	1.188118811881188	0.9107757110849387	KSR1;RIPK3;MADD
Corticotropin releasing hormone pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	POMC
Ghrelin pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	ABCA1
Interferon alpha signaling regulation	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	STAT2
PIP2 hydrolysis	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	PRKCH
Proteasome degradation	2/63	0.46961389196045544	1.0	0	0	1.2698412698412698	0.9598024487193709	UBA7;HLA-G
Folate metabolism	2/63	0.46961389196045544	1.0	0	0	1.2698412698412698	0.9598024487193709	ABCA1;CBS
O-linked glycosylation of mucins	2/63	0.46961389196045544	1.0	0	0	1.2698412698412698	0.9598024487193709	B3GNT8;GALNTL6
EGF/EGFR signaling pathway	4/141	0.4705633518217357	1.0	0	0	1.1347517730496453	0.8554038935072336	RPS6KA2;PIK3R2;SOS2;EPS15
MHC class II antigen presentation	3/103	0.47747528768906305	1.0	0	0	1.1650485436893203	0.8612538337064508	CTSO;CTSF;OSBPL1A
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin	2/64	0.47782308073315993	1.0	0	0	1.25	0.9231434237408449	PRKCH;PLCD4
Validated nuclear estrogen receptor alpha network	2/64	0.47782308073315993	1.0	0	0	1.25	0.9231434237408449	CALCOCO1;TRIM59
MAPK cascade role in angiogenesis	2/64	0.47782308073315993	1.0	0	0	1.25	0.9231434237408449	PLXND1;TIMP2
Physiological and pathological hypertrophy  of the heart	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	NFATC4
Selective expression of chemokine receptors during T-cell polarization	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	CD4
Selenoamino acid metabolism	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	CBS
CARM1 and regulation of the estrogen receptor	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	HDAC6
Steroid biosynthesis	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	FDFT1
Tetrasaccharide linker sequence formation in glycosaminoglycan biosynthesis	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	BCAN
YAP1- and WWTR1 (TAZ)-stimulated gene expression	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	RXRA
Interleukin-27-mediated signaling events	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	STAT2
Interleukin-12-mediated signaling events	2/65	0.48595425402499	1.0	0	0	1.2307692307692308	0.8881732763477085	EOMES;CD4
Retinoblastoma protein regulation	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	CDKN1B;PAX3
Semaphorin interactions	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	PLXND1;FES
HIF-1 transcriptional activity in hypoxia	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	TFF3;ETS1
ADP signalling through P2Y purinoceptor 12	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	P2RY12
Proteins and DNA sequences in cardicac structures	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	NFATC4
RORA activates circadian expression	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	RXRA
BAD phosphorylation regulation	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	KIT
Collecting duct acid secretion	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	ATP6V0D1
Control of gene expression by vitamin D receptor	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	RXRA
EGFR downregulation	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	EPS15
Insulin regulation of blood glucose	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	VAMP2
Interleukin-4 regulation of apoptosis	7/267	0.5028413129626041	1.0	0	0	1.048689138576779	0.7209534799869748	PPP1R16B;CYSLTR2;KIT;TIMP2;CYP1B1;MAL;CYTH1
Recycling pathway of cell adhesion molecule L1	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	RPS6KA2
Cell cycle: G1/S checkpoint	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	CDKN1B
Dual incision reaction in TC-NER	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	ERCC5
G-protein activation	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	POMC
Interleukin receptor SHC signaling	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	PIK3R2
Nef in HIV-1 replication and disease pathogenesis	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	CD4
Transmembrane transport of small molecules	11/432	0.5183003019454668	1.0	0	0	1.0185185185185184	0.6693708503143591	SLC6A6;SLC35A1;ADCY9;ATP8A1;FTH1;CYBRD1;ATP6V0D1;ABCG4;ADCY6;SLC38A5;ADCY5
Wnt signaling pathway	6/231	0.5199017221199351	1.0	0	0	1.0389610389610389	0.67960049993958	PRKCH;TLE1;DVL3;TSC1;NLK;NFATC4
ADP-ribosylation factor	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	CYTH1
Pentose and glucuronate interconversions	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	CRYL1
Post-translational modification: biosynthesis of GPI-anchored proteins	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	PIGQ
Amine compound SLC transporters	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	SLC6A6
Reelin signaling pathway	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	MAP3K11
Transferrin endocytosis and recycling	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	ATP6V0D1
Histidine metabolism	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	HNMT
Influence of Ras and Rho proteins on G1 to S transition	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	CDKN1B
Matrix metalloproteinases	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	TIMP2
Pancreatic cancer	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	VEGFB;PIK3R2
AP-1 transcription factor network	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	CDKN1B;ETS1
Complement and coagulation cascades	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	SERPING1;CD59
Long-term depression	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	CACNA1A;GRIA3
Long-term potentiation	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	RPS6KA2;GRIN2D
EGFR1 pathway	4/152	0.5292001078705473	1.0	0	0	1.0526315789473684	0.6698827820045727	SELENBP1;GRN;PIK3IP1;PBXIP1
Activation of matrix metalloproteinases	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	TIMP2
Apoptosis intrinsic pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	BMF
Retinoic acid receptor-mediated signaling	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	RXRA
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	ALG9
Butanoate metabolism	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	BDH2
CDC42 activity regulation	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	MCF2
Signaling pathway from G-protein families	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	NFATC4
TNFR1 signaling pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	MADD
Tight junction interactions	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	CLDN7
p38-alpha and p38-beta regulation	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	MAP3K12
Gap junction trafficking and regulation	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	DAB2
Glutamate binding and activation of AMPA receptors and synaptic plasticity	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	GRIA3
Inflammatory response pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	LAMB2
Interferon-beta enhancer pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	IRF6
MicroRNAs in muscle cell differentiation	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	PRKCH
O-glycan biosynthesis	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	GALNTL6
Ovarian infertility genes	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	CDKN1B
Phase II of biological oxidations: conjugation	2/71	0.533041249161984	1.0	0	0	1.1267605633802817	0.7089086955075764	GSTP1;OPLAH
Rac1 cell motility signaling pathway	2/71	0.533041249161984	1.0	0	0	1.1267605633802817	0.7089086955075764	CDH1;MAP3K11
Interleukin-6 signaling pathway	2/71	0.533041249161984	1.0	0	0	1.1267605633802817	0.7089086955075764	PIK3R2;NLK
Melanoma	2/71	0.533041249161984	1.0	0	0	1.1267605633802817	0.7089086955075764	CDH1;PIK3R2
Phagosome	4/154	0.5395222877080957	1.0	0	0	1.0389610389610389	0.6411129177684076	RAB5B;STX18;ATP6V0D1;HLA-G
Amino acid metabolism	5/195	0.5400553403402075	1.0	0	0	1.0256410256410255	0.6318806795520557	ACAD8;POMC;AUH;CBS;HAAO
Costimulation by the CD28 family	2/72	0.5405975770602098	1.0	0	0	1.111111111111111	0.6834223634393684	CD4;PIK3R2
Activated NOTCH1 signaling in the nucleus	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	APH1B
Prostaglandin biosynthesis and regulation	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	PTGDS
Ras family activation regulation	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	SOS2
Signal amplification	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	P2RY12
CD28 co-stimulation	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	PIK3R2
Transport of vitamins, nucleosides, and related molecules	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	SLC35A1
Keratan sulfate/keratin metabolism	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	PRELP
One-carbon metabolism	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	ALDH1L2
PD-1 signaling	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	CD4
Post-translational protein modification	5/196	0.5446077411464911	1.0	0	0	1.0204081632653061	0.6200913106861422	ALG9;B3GNT8;PIGQ;MLEC;GALNTL6
Myometrial relaxation and contraction pathways	4/155	0.5446402358822579	1.0	0	0	1.032258064516129	0.6272307818732501	PRKCH;ADCY9;ADCY6;ADCY5
Seven transmembrane receptor signaling through beta-arrestin	2/74	0.5554545611303542	1.0	0	0	1.0810810810810811	0.635641590695438	PDE6G;PDE9A
Prothrombin activation intrinsic pathway	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	SERPING1
Signaling by Robo receptor	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	SOS2
Fibrin clot formation (clotting cascade)	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	SERPING1
CXCR4 signaling pathway	3/116	0.5572700711982903	1.0	0	0	1.0344827586206895	0.604867540410722	CD4;STAT2;PIK3R2
Prolactin activation of MAPK signaling	2/75	0.5627543403864517	1.0	0	0	1.0666666666666667	0.6132395588377343	RPS6KA2;PIK3R2
Leukocyte transendothelial migration	3/117	0.5631014915681113	1.0	0	0	1.0256410256410255	0.5890209208962783	CTNND1;CLDN7;PIK3R2
Toll receptor cascades	4/159	0.5648130577623949	1.0	0	0	1.0062893081761006	0.5748533069712247	DUSP3;RIPK3;RPS6KA2;IRAK3
E2F-mediated regulation of DNA replication	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	TK2
Global genomic nucleotide excision repair (GG-NER)	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	ERCC5
Glycoprotein VI-mediated activation cascade	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	PIK3R2
Negative regulators of RIG-I/MDA5 signaling	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	UBA7
PIP biosynthesis at the plasma membrane	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	PIK3R2
Lipid and lipoprotein metabolism	12/489	0.5673071342143218	1.0	0	0	0.9815950920245399	0.5564215352087782	ABCA1;MED12;POMC;LIPE;CERS4;NEU3;COL4A3BP;RXRA;PIK3R2;ACOX3;PLTP;FDFT1
Transcriptional regulation of white adipocyte differentiation	2/77	0.5770948361053473	1.0	0	0	1.0389610389610389	0.571167444479923	MED12;RXRA
Cysteine and methionine metabolism	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	CBS
EPO receptor signaling	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	PTPRU
Fatty acid beta oxidation	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	LIPE
HIF-2-alpha transcription factor network	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	ETS1
Interleukin-7 interactions in immune response	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	RAG1
MAPK/TRK pathway	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	RIT1
N-cadherin signaling events	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	CTNND1
Nuclear receptors in lipid metabolism and toxicity	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	ABCA1
Phosphatidylinositol signaling system	2/78	0.5841351052931448	1.0	0	0	1.0256410256410255	0.5514081827999194	PIK3R2;PLCD4
Platelet activation, signaling and aggregation	5/205	0.5845765351238086	1.0	0	0	0.975609756097561	0.5237732345902935	P2RY12;PRKCH;VEGFB;SERPING1;PIK3R2
Signal transduction by L1	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	RPS6KA2
Cytokines and inflammatory response	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	CD4
EGF receptor (ErbB1) signaling pathway	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	PIK3R2
fMLP induced chemokine gene expression in HMC-1 cells	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	NFATC4
Interleukin-2/PI3K pathway	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	FOXO3
MEF2D role in T cell apoptosis	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	CD4
p73 transcription factor network	2/79	0.591088531821221	1.0	0	0	1.0126582278481011	0.5324450357053537	WWOX;FOXO3
Fc epsilon receptor I signaling pathway	2/79	0.591088531821221	1.0	0	0	1.0126582278481011	0.5324450357053537	PIK3R2;SOS2
Steroid hormone, vitamin A, and vitamin D metabolism	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	POMC
Generation of second messenger molecules	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	CD4
Ion transport by P-type ATPases	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	ATP8A1
Neurotransmitter release cycle	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	VAMP2
PI3K/PLC/TRK pathway	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	FOXO3
p75 neurotrophin receptor-mediated signaling	3/124	0.6025842683865784	1.0	0	0	0.9677419354838709	0.49018815373105273	APH1B;MCF2;SOS2
Antigen processing and presentation	2/81	0.6047346486005095	1.0	0	0	0.9876543209876543	0.49675606372126246	CD4;HLA-G
Allograft rejection	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	HLA-G
Interleukin-23-mediated signaling events	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	CD4
Latent infection of Homo sapiens with Mycobacterium tuberculosis	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	ATP6V0D1
Platelet homeostasis	2/82	0.611427375574375	1.0	0	0	0.975609756097561	0.4799600929754372	PDE6G;PDE9A
Response to elevated platelet cytosolic calcium	2/83	0.6180333278447322	1.0	0	0	0.963855421686747	0.4638196572792209	VEGFB;SERPING1
RAC1 activity regulation	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	MCF2
BMAL1-CLOCK/NPAS2 activates circadian expression	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	RXRA
Signal transduction through IL-1R	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	IRAK3
Cyclin D-associated events in G1	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	CDKN1B
Trefoil factor initiation of mucosal healing	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	TFF3
Glycosphingolipid metabolism	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	NEU3
Nuclear receptors	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	RXRA
Aurora B signaling	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	TACC1
G13 signaling pathway	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	PIK3R2
Asparagine N-linked glycosylation	2/85	0.6309855429295065	1.0	0	0	0.9411764705882353	0.433385720533733	ALG9;MLEC
Integrin cell surface interactions	2/85	0.6309855429295065	1.0	0	0	0.9411764705882353	0.433385720533733	CDH1;LAMB2
MicroRNAs in cardiomyocyte hypertrophy	2/85	0.6309855429295065	1.0	0	0	0.9411764705882353	0.433385720533733	PIK3R2;NFATC4
Fatty acid, triacylglycerol, and ketone body metabolism	4/173	0.631337646709537	1.0	0	0	0.9248554913294796	0.42535441549899206	ABCA1;MED12;RXRA;FDFT1
Parkinson's disease	3/131	0.6396436458477918	1.0	0	0	0.916030534351145	0.4093228040279114	UBA7;COX7A1;SLC25A6
Alpha-M beta-2 integrin signaling	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	MST1R
Tyrosine metabolism	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	TYRP1
Fc epsilon receptor I signaling in mast cells	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	NFATC4
Graft-versus-host disease	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	HLA-G
Insulin biosynthesis and processing	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	VAMP2
BMP receptor signaling	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	CTDSP2
Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP)	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	PIK3R2
Fatty acid metabolism	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	ACOX3
TNF-alpha effects on cytokine activity, cell motility, and apoptosis	3/135	0.6597044758695414	1.0	0	0	0.8888888888888888	0.36974516273053687	FNBP1;ETS1;OPTN
Mitotic prometaphase	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	REC8
PI3K class IB pathway in neutrophils	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	PRKCH
Ubiquitin-mediated proteolysis	3/136	0.6645919082134366	1.0	0	0	0.8823529411764706	0.36051361637596113	HERC3;UBA7;MGRN1
HNF3A pathway	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	CDKN1B
Interactions of HIV Vpr protein with host cellular proteins	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	SLC25A6
Lysine degradation	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	NSD1
p53 signaling pathway	3/139	0.678947280053301	1.0	0	0	0.8633093525179856	0.3342835665780219	TYRP1;HTT;TNFRSF10D
Amino sugar and nucleotide sugar metabolism	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	UAP1L1
RhoA signaling pathway	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	CDKN1B
Defensins	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	CD4
Integrin-linked kinase signaling	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	LIMS2
Interleukin-12/STAT4 pathway	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	CD4
Interleukin-3, interleukin-5, and GM-CSF signaling	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	PIK3R2
Fc gamma receptor-mediated phagocytosis	2/94	0.6850442087819228	1.0	0	0	0.8510638297872339	0.3219335356890655	MARCKSL1;PIK3R2
Innate immune system	7/319	0.6885833680990986	1.0	0	0	0.8777429467084639	0.32750246659070675	PANX1;CD4;DUSP3;RIPK3;UBA7;RPS6KA2;IRAK3
Transport of inorganic cations/anions and amino acids/oligopeptides	2/95	0.6906320962251579	1.0	0	0	0.8421052631578947	0.31170359515928925	SLC6A6;SLC38A5
Focal adhesion	5/233	0.6956170276203147	1.0	0	0	0.8583690987124463	0.3115502298381849	SHC2;LAMB2;VEGFB;PIK3R2;SOS2
Agrin in postsynaptic differentiation	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	LAMB2
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	PANX1
TSH regulation of gene expression	2/97	0.7015629289067601	1.0	0	0	0.8247422680412371	0.29232550701224613	VEGFB;CYP1B1
N-glycan biosynthesis	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	ALG9
Downstream signaling events Of B cell receptor (BCR)	2/98	0.7069070769803031	1.0	0	0	0.8163265306122448	0.283147799645867	CDKN1B;FOXO3
Peptide G-protein coupled receptors	4/192	0.710534146303129	1.0	0	0	0.8333333333333333	0.2847818942165517	HEBP1;POMC;ATP8A1;RLN2
Senescence and autophagy	2/99	0.712171216084855	1.0	0	0	0.8080808080808081	0.27429246420172493	CDKN1B;GABARAP
Phosphatidylinositol metabolism	1/50	0.7184542048692922	1.0	0	0	0.7999999999999999	0.26452265010260456	PIK3R2
Signal transduction	23/1020	0.725486774552766	1.0	0	0	0.9019607843137254	0.28945043269447346	DUSP3;CDKN1B;CAB39L;LAMB2;MCF2;FAM13A;HDAC11;FOXO3;FSTL1;ADCY6;HDAC6;ADCY5;HEBP1;HEYL;ADCY9;CYSLTR2;APH1B;CDH1;FES;KIT;ATP6V0D1;EPS15;HES5
Metabolism of vitamins and cofactors	1/51	0.7255104548045064	1.0	0	0	0.7843137254901961	0.25167042845488546	NADSYN1
Nuclear receptor transcription pathway	1/51	0.7255104548045064	1.0	0	0	0.7843137254901961	0.25167042845488546	RXRA
Signaling by the B cell receptor (BCR)	3/151	0.7317997732945651	1.0	0	0	0.7947019867549668	0.2481443731300127	CD79B;CDKN1B;FOXO3
Autoimmune thyroid disease	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	HLA-G
Drug metabolism: other enzymes	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	TK2
Mitochondrial protein import	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	SLC25A6
Thrombin signaling through protease-activated receptors	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	CYTH1
Electron transport chain	2/105	0.7421134845024052	1.0	0	0	0.761904761904762	0.22724045976090407	COX7A1;SLC25A6
RANKL signaling pathway	1/54	0.7456376971972923	1.0	0	0	0.7407407407407407	0.21741885729120122	PIK3R2
ERBB1 downstream pathway	2/106	0.7468366874546598	1.0	0	0	0.7547169811320754	0.22030848476214387	KSR1;PIK3R2
Integrin signaling pathway	3/155	0.7478227718898713	1.0	0	0	0.7741935483870968	0.22497233423808818	SHC2;SOS2;MAP3K11
Basal cell carcinoma	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	DVL3
Calcineurin-dependent NFAT signaling role in lymphocytes	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	PRKCH
Meiotic synapsis	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	REC8
Phospholipid metabolism	4/205	0.757118371611701	1.0	0	0	0.7804878048780487	0.2171595460690251	NEU3;CERS4;COL4A3BP;PIK3R2
Steroid hormone biosynthesis	1/56	0.758230644178816	1.0	0	0	0.7142857142857142	0.19769118550302078	CYP1B1
Cytosolic DNA-sensing pathway	1/56	0.758230644178816	1.0	0	0	0.7142857142857142	0.19769118550302078	RIPK3
Thromboxane A2 receptor signaling	1/56	0.758230644178816	1.0	0	0	0.7142857142857142	0.19769118550302078	PRKCH
Gastrin-CREB signaling pathway via PKC and MAPK	4/206	0.7604494266616241	1.0	0	0	0.7766990291262135	0.21269566571668186	PRKCH;CYSLTR2;RPS6KA2;PIK3R2
Signaling by interleukins	2/109	0.7605630710629657	1.0	0	0	0.7339449541284404	0.20087797214127237	PIK3R2;IRAK3
Pathogenic Escherichia coli infection	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	CDH1
Inositol phosphate metabolism	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	PLCD4
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	RXRA
Nucleotide excision repair	1/58	0.770201320910123	1.0	0	0	0.689655172413793	0.18007127074521875	ERCC5
Caspase cascade in apoptosis	1/59	0.7759629585959883	1.0	0	0	0.6779661016949152	0.1719664364110286	MADD
RAGE pathway	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	CDKN1B
BDNF signaling pathway	5/261	0.7844682863236204	1.0	0	0	0.7662835249042145	0.18601466127397873	PPP1R16B;FEM1B;PLEKHA6;FOXO3;OSBPL1A
Androgen receptor proteolysis and transcription regulation	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	CTDSP2
Ion channel transport	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	ATP8A1
Leptin signaling pathway	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	PIK3R2
Circadian rhythm	1/62	0.7923971144117075	1.0	0	0	0.6451612903225806	0.15012426177080712	RXRA
Colorectal cancer	1/62	0.7923971144117075	1.0	0	0	0.6451612903225806	0.15012426177080712	PIK3R2
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell	2/119	0.8017528596829252	1.0	0	0	0.6722689075630252	0.14854109150517988	CDH1;HLA-G
Retinol metabolism	1/65	0.8076279713191508	1.0	0	0	0.6153846153846154	0.13147923570947304	RETSAT
Beta-1 integrin cell surface interactions	1/66	0.8124529129968876	1.0	0	0	0.6060606060606061	0.12587716344981695	LAMB2
SIDS susceptibility pathways	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	HES5
T cell receptor signaling in naive CD4+ T cells	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	CD4
Telomerase regulation	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	CDKN1B
G1 to S cell cycle control	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	CDKN1B
CD8/T cell receptor downstream pathway	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	EOMES
Epithelial cell signaling in Helicobacter pylori infection	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	ATP6V0D1
Messenger RNA splicing: major pathway	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	RBM5
Immune system	21/998	0.8217897655143896	1.0	0	0	0.8416833667334669	0.16519776366376787	DUSP3;CDKN1B;RIPK3;UBA7;MGRN1;STAT2;PIK3R2;IRAK3;FOXO3;HLA-G;IFIT2;PANX1;CD79B;CD4;CTSO;CDH1;RPS6KA2;CTSF;IRF6;OSBPL1A;IRF9
Interleukin-1 signaling pathway	2/125	0.8233393070687913	1.0	0	0	0.64	0.12440760480345983	PIK3R2;IRAK3
NFAT involvement in hypertrophy of the heart	1/69	0.8262150460248844	1.0	0	0	0.5797101449275363	0.11066677859030163	NFATC4
T cell receptor regulation of apoptosis	12/603	0.8275372469547493	1.0	0	0	0.7960199004975124	0.15068749159659622	CDKN1B;FEM1B;GSTP1;TSC22D3;PRUNE2;HTT;MAL;BMF;HLA-G;MAP3K12;RCBTB2;BPTF
Antiviral mechanism by interferon-stimulated genes	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	UBA7
Signaling events mediated by VEGFR1 and VEGFR2	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	FES
G alpha q pathway	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	PRKCH
Hedgehog signaling pathway	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	DISP1
MicroRNA regulation of DNA damage response	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	CDKN1B
Nucleotide metabolism	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	TK2
Adaptive immune system	12/606	0.8323616660927949	1.0	0	0	0.792079207920792	0.14533721805170788	CD79B;CD4;CTSO;CDKN1B;UBA7;CDH1;MGRN1;PIK3R2;CTSF;FOXO3;OSBPL1A;HLA-G
HIV factor interactions with host	2/128	0.8333219827301188	1.0	0	0	0.625	0.11395948600660934	CD4;SLC25A6
RIG-I-like receptor signaling pathway	1/71	0.8348251375727604	1.0	0	0	0.5633802816901409	0.10170872796755898	DDX3Y
Viral myocarditis	1/71	0.8348251375727604	1.0	0	0	0.5633802816901409	0.10170872796755898	HLA-G
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	1/71	0.8348251375727604	1.0	0	0	0.5633802816901409	0.10170872796755898	PRKCH
PDGFB signaling pathway	2/129	0.8365348024648527	1.0	0	0	0.6201550387596899	0.11068970825510628	KSR1;PIK3R2
Cyclin A-Cdk2-associated events at S phase entry	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	CDKN1B
Leishmaniasis	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	MARCKSL1
Huntington's disease	3/184	0.8421071805445673	1.0	0	0	0.6521739130434782	0.11207476958646365	HTT;COX7A1;SLC25A6
Carbohydrate metabolism	4/235	0.8423229678285881	1.0	0	0	0.6808510638297872	0.11682843645403129	BCAN;CHST9;HPSE2;PRELP
Degradation of beta-catenin by the destruction complex	1/73	0.8430094520012101	1.0	0	0	0.547945205479452	0.09357649792044484	CD4
Integrins in angiogenesis	1/74	0.8469485510129866	1.0	0	0	0.5405405405405406	0.08979206961117422	CDKN1B
Tight junction	2/133	0.8488334569866297	1.0	0	0	0.6015037593984962	0.09858181994056327	PRKCH;CLDN7
RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways	1/76	0.8545332771182171	1.0	0	0	0.5263157894736842	0.08273675463408255	UBA7
Mitotic G1-G1/S phases	2/135	0.8546621232629286	1.0	0	0	0.5925925925925926	0.09306611295930632	CDKN1B;TK2
Oxidative phosphorylation	2/136	0.8574989856214092	1.0	0	0	0.588235294117647	0.09043251934796212	ATP6V0D1;COX7A1
Mitochondrial pathway of apoptosis: caspases	1/77	0.8581837738781999	1.0	0	0	0.5194805194805194	0.07944779935587648	DNASE1
Peroxisome	1/78	0.8617428383211508	1.0	0	0	0.5128205128205128	0.07630686371389282	ACOX3
Apoptosis regulation	1/78	0.8617428383211508	1.0	0	0	0.5128205128205128	0.07630686371389282	CDKN1B
Disease	13/674	0.8647895554902149	1.0	0	0	0.771513353115727	0.11207704280736266	CDKN1B;WFS1;FOXO3;ADCY6;ADD1;ADCY5;CD4;ADCY9;CTDSP2;ATP6V0D1;EPS15;VAMP2;SLC25A6
Antigen processing: cross presentation	1/79	0.8652127562704516	1.0	0	0	0.5063291139240506	0.07330624875311624	HLA-G
Glycerophospholipid metabolism	1/79	0.8652127562704516	1.0	0	0	0.5063291139240506	0.07330624875311624	PLA2G15
Protein metabolism	8/442	0.8660770200020739	1.0	0	0	0.7239819004524887	0.10409515781189745	FBXW4;ALG9;B3GNT8;PIGQ;MLEC;GALNTL6;FBXL5;SLC25A6
Cardiac muscle contraction	1/80	0.868595756144096	1.0	0	0	0.5	0.07043872237547145	COX7A1
Toll-like receptor signaling pathway regulation	2/142	0.8734829514627659	1.0	0	0	0.5633802816901409	0.07620657301387117	PIK3R2;IRAK3
Regular glucocorticoid receptor pathway	1/82	0.8751096392159449	1.0	0	0	0.4878048780487805	0.0650761456161355	POMC
SMAD2/3 nuclear pathway	1/82	0.8751096392159449	1.0	0	0	0.4878048780487805	0.0650761456161355	FOXO3
Meiosis	1/83	0.8782447070953916	1.0	0	0	0.4819277108433735	0.06256868168843485	REC8
ECM-receptor interaction	1/84	0.8813012287674056	1.0	0	0	0.47619047619047616	0.060169426005052117	LAMB2
Non-class A, B, C GPCRs	1/86	0.8871864408298141	1.0	0	0	0.46511627906976744	0.055674477287034875	CELSR2
Oncostatin M	5/311	0.891637010791982	1.0	0	0	0.6430868167202571	0.07375959343929911	SELENBP1;HOXA9;CDKN1B;CBS;TIMP2
DNA replication pre-Initiation	1/88	0.8927804067909452	1.0	0	0	0.45454545454545453	0.051552106088443475	CDKN1B
HIF-1 degradation in normoxia	1/88	0.8927804067909452	1.0	0	0	0.45454545454545453	0.051552106088443475	USP20
Thymic stromal lymphopoietin (TSLP) pathway	1/90	0.8980975124258875	1.0	0	0	0.4444444444444444	0.047767390278977744	CLDN7
Hemostasis pathway	8/468	0.9021600626665227	1.0	0	0	0.6837606837606838	0.07040227117630644	P2RY12;PRKCH;PDE6G;DOCK8;VEGFB;SERPING1;PIK3R2;PDE9A
Developmental biology	7/420	0.90366568620665	1.0	0	0	0.6666666666666666	0.06753053542126702	MED12;RXRA;PLXND1;FES;RPS6KA2;FOXO3;SOS2
Extracellular matrix organization	1/93	0.9055837893531324	1.0	0	0	0.43010752688172044	0.04265611705062928	TIMP2
Cell surface interactions at the vascular wall	1/94	0.9079551737327357	1.0	0	0	0.42553191489361697	0.041089476483082504	PIK3R2
L1CAM interactions	1/94	0.9079551737327357	1.0	0	0	0.42553191489361697	0.041089476483082504	RPS6KA2
Axon guidance	5/325	0.9118663792284842	1.0	0	0	0.6153846153846154	0.05677650070516051	PLXND1;FES;RPS6KA2;SOS2;NFATC4
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	1/96	0.9125210926536497	1.0	0	0	0.41666666666666663	0.038143366064902956	SLC6A6
Pyrimidine metabolism	1/100	0.9209858941252744	1.0	0	0	0.39999999999999997	0.03292422346760427	TK2
Integrin-mediated cell adhesion	1/100	0.9209858941252744	1.0	0	0	0.39999999999999997	0.03292422346760427	PIK3R2
Chromosome maintenance	1/103	0.9267934783334831	1.0	0	0	0.38834951456310673	0.029524086681869306	REC8
Alzheimer's disease	2/169	0.9269034574549694	1.0	0	0	0.47337278106508873	0.035931769931377006	COX7A1;GRIN2D
Chagas disease	1/104	0.9286330649622538	1.0	0	0	0.38461538461538464	0.028477537194216435	PIK3R2
DNA repair	1/105	0.9304265136935658	1.0	0	0	0.380952380952381	0.027471307082899035	ERCC5
Cytoplasmic ribosomal proteins	1/108	0.9355414383081698	1.0	0	0	0.37037037037037035	0.02467771810747774	RPS6KA2
S phase	1/112	0.941782260555401	1.0	0	0	0.3571428571428571	0.021421848939758598	CDKN1B
Cell cycle checkpoints	1/117	0.9487420365553102	1.0	0	0	0.3418803418803419	0.01798917741029584	CDKN1B
Prolactin regulation of apoptosis	1/118	0.9500309723481404	1.0	0	0	0.3389830508474576	0.01737650591432978	FTH1
HIV life cycle	1/118	0.9500309723481404	1.0	0	0	0.3389830508474576	0.01737650591432978	CD4
SLC-mediated transmembrane transport	3/251	0.9521828455366843	1.0	0	0	0.4780876494023904	0.023425433303640945	SLC6A6;SLC35A1;SLC38A5
Class A GPCRs (rhodopsin-like)	3/253	0.9539457666461015	1.0	0	0	0.47430830039525684	0.02236290475689931	P2RY12;CYSLTR2;OR7C1
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	3/255	0.9556478694704547	1.0	0	0	0.47058823529411764	0.021348598191816497	UBA7;MGRN1;HLA-G
Factors involved in megakaryocyte development and platelet production	1/125	0.9581917112507288	1.0	0	0	0.32	0.013666369569193149	DOCK8
HIV infection	2/200	0.9619058912414412	1.0	0	0	0.39999999999999997	0.01553546370162748	CD4;SLC25A6
Cytokine-cytokine receptor interaction	3/265	0.9633104172457615	1.0	0	0	0.45283018867924524	0.016926600069244416	KIT;VEGFB;TNFRSF10D
Neuroactive ligand-receptor interaction	3/272	0.9679141811008485	1.0	0	0	0.4411764705882353	0.014387581554387682	CYSLTR2;GRIA3;GRIN2D
Capped intron-containing pre-mRNA processing	1/138	0.9699823237314814	1.0	0	0	0.2898550724637681	0.008834037857386757	RBM5
Influenza infection	1/142	0.9728927010915251	1.0	0	0	0.28169014084507044	0.007741261759857956	SLC25A6
Interleukin-5 regulation of apoptosis	1/144	0.9742404896710359	1.0	0	0	0.27777777777777773	0.007249193473197562	FEZ1
GPCR ligand binding	5/410	0.9773987730897307	1.0	0	0	0.4878048780487805	0.011151487525101705	P2RY12;HEBP1;POMC;CYSLTR2;RLN2
Actin cytoskeleton regulation	2/226	0.9782574479403496	1.0	0	0	0.35398230088495575	0.007781382083493099	PIK3R2;SOS2
Protein processing in the endoplasmic reticulum	1/166	0.9853052365984427	1.0	0	0	0.24096385542168675	0.0035671809501042298	WFS1
Generic transcription pathway	4/377	0.9858596461022441	1.0	0	0	0.42440318302387264	0.00604404509880109	MED12;ZNF154;RXRA;ZNF233
Cell cycle	5/453	0.9892791105732116	1.0	0	0	0.4415011037527594	0.004758839839755086	CDKN1B;CDH1;TK2;HDAC6;REC8
Signaling by GPCR	14/977	0.9930620147123344	1.0	0	0	0.5731832139201637	0.00399059611715647	P2RY12;PRKCH;MCF2;PIK3R2;ADCY6;ADCY5;HEBP1;POMC;ADCY9;CYSLTR2;RPS6KA2;RLN2;SOS2;OR7C1
Messenger RNA processing	1/203	0.9942900918821206	1.0	0	0	0.19704433497536944	0.0011283294509696132	RBM5
DNA replication	1/207	0.9948452256492291	1.0	0	0	0.19323671497584538	9.98667832725851E-4	CDKN1B
Olfactory transduction	2/432	0.999802399144242	1.0	0	0	0.18518518518518517	3.6596366922104964E-5	GUCA1A;OR7C1
Gene expression	5/968	0.9999952787907099	1.0	0	0	0.2066115702479339	9.75458767564926E-7	MED12;ZNF154;RXRA;RBM5;ZNF233
